In summary, our results show that increased autophagic removal of mitochondria plays an important role in mitochondrial diseases caused by mutations in FBXL4. Further studies are needed to explore the therapeutic potential of these findings, in particular whether inhibition of autophagy may provide a strategy for treatment of affected patients. The gene discussed is FBXL4; the disease is mitochondrial disease.